Venetoclax, AZACITIDINE, Venetoclax, azacitidine, Venetoclax, azacitidine
M19-708
Phase 3 small_molecule active
Quick answer
Venetoclax, AZACITIDINE, Venetoclax, azacitidine, Venetoclax, azacitidine for Acute Myeloid Leukemia in First Remission is a Phase 3 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie Deutschland GmbH & Co. KG
- Indication
- Acute Myeloid Leukemia in First Remission
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active